Interaction databaseSupplement × PrescriptionReviewed May 2026

Alpha-Lipoic Acid and Insulin Lispro, a caution.

Alpha-lipoic acid may improve glycemic control and insulin sensitivity in diabetes, and rare case reports link it to insulin autoimmune syndrome with severe hypoglycemia. Insulin lispro already has a rapid glucose-lowering effect around meals, so added glucose-lowering or unexpected autoimmune hypoglycemia can make lows more likely. The risk is greatest with tight insulin dosing, low-carbohydrate intake, exercise, alcohol, or prior unexplained lows.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Alpha-Lipoic Acid and Insulin Lispro
Pair type
Caution
Evidence (highest tier)
Emerging
Source citations
3 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Emerging evidence

Caution

What is happening. Alpha-lipoic acid may improve glycemic control and insulin sensitivity in diabetes, and rare case reports link it to insulin autoimmune syndrome with severe hypoglycemia. Insulin lispro already has a rapid glucose-lowering effect around meals, so added glucose-lowering or unexpected autoimmune hypoglycemia can make lows more likely. The risk is greatest with tight insulin dosing, low-carbohydrate intake, exercise, alcohol, or prior unexplained lows.

Mechanism. Alpha-lipoic acid may improve insulin-mediated glucose uptake and metabolic control. In susceptible patients, its sulfhydryl-related chemistry can trigger insulin autoantibodies, causing delayed hyperinsulinemic hypoglycemia independent of insulin dose timing.

Recommendation. Use alpha-lipoic acid with insulin lispro only with extra glucose monitoring. Check glucose more often for 1-2 weeks after starting or changing the dose, including after meals and overnight if you have a CGM or a history of nocturnal lows. Stop alpha-lipoic acid and contact your clinician for repeated unexplained hypoglycemia.

Sources (3)
  1. Ebada MA, Fayed N, Fayed L, Alkanj S, Abdelkarim A, Youssef G, et al. Efficacy of Alpha-lipoic Acid in The Management of Diabetes Mellitus: A Systematic Review and Meta-analysis. Iran J Pharm Res. 2019;18(4):2144-2156. PMID 32184879
  2. Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 2007;46(5):237-239. PMID 17329919
  3. Moffa S, Improta I, Rocchetti S, Mezza T, Giaccari A. Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports. Nutrition. 2019;57:1-4. PMID 30086435

Stack Score

How this pair moves the number.

Effect on the composite score

If both Alpha-Lipoic Acid and Insulin Lispro are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.